






















Thymoquinone Inhibits Inflammation in IL-1β-Stimulated SK-N-SH cells 
Thymoquinone is a phytochemical antioxidant compound in the oil obtained from the 
seeds of Nigella sativa (black cumin seed oil). Studies have suggested 
that thymoquinone produces anti-inflammatory property. Previously, we have shown 
that thymoquuinone inhibited neuroinflammation in LPS-activated rat priamry 
microglia. However, nothing is known about its direct effect on neurons. In this study, 
we have investigated the effects of thymoquinone on inflammation induced in 
SK-N-SH neuroblastoma cells stimulated with interleukin-1beta (IL-1β). Cultured 
SK-N-SH cells were treated with thymoquinone (0.5, 1 and 2.5 µM) prior to 
stimulation with IL-1β. Levels of prostaglandin E2 (PGE2) production was 
measured using enzyme immunoassay (EIA), while ELISAs were used to detect 
levels of pro-inflammatory cytokines tumour necrosis factor-alpha 
(TNFα) and interleukin-6 (IL-6). Levels of cyclooxygenase-2 (COX-2, microsomal 
prostaglandin E synthase-1 (mPGES-1) were measured with western blot. Further 
experiments were carried out on IκB phosphorylation and degradation using western 
blots. Results showed that thymoquinone (0.5, 1 and 2.5 µM) produced 
concentration-dependent and significant inhibition of PGE2, TNFα and IL-6. These 
concentrations of the compound also reduced protein levels of COX-2 and mPGES-
1. At 1 and 2.5 µM, there was marked inhibition of IκB phosphorylation and 
degradation by this compound. Taken together, these results demonstrate that 
thymoquinone suppressed inflammation in neurons, suggesting its therapeutic 
potential in inflammation-mediated neuronal damage found in neurodegenerative 
disorders. 
